| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Vtv Therapeutics Inc. (VTVT) has 6 insiders with recent SEC Form 4 filings, including 13 buys and 1 sell. VTVT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Dir | 2.40M | $74.51M | - | |
| Dir | 106.0K | $3.29M | - | |
| CFO | 45.0K | $1.40M | - | |
| Dir | 13.6K | $420.7K | - | |
| Dir | 10.9K | $337.1K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 18, 2024 | Sekhri Paul J63 | Pres, CEO And Exec Chairperson | Buy | 5,000 | $16.76 | $83,811.94 | +110.3% | +15.3% | +78.2% | |
| Nov 29, 2022 | Fry John A | Director | Buy | 61,000 | $0.83 | $50,742.12 | +297.0% | -7.2% | -55.8% | |
| Dec 20, 2021 | Perelman Ronald O | 10% Owner | Sell | 87,000 | $1.15 | $100,050.00 | -0.2% | -38.8% | -34.6% | |
| Feb 26, 2021 | Nelson Rich S. | Director | Buy | 60,000 | $2.86 | $171,600.00 | New | - | - | |
| Feb 26, 2021 | Kozlov Hersh | Director | Buy | 10,000 | $2.74 | $27,400.00 | +66.7% | - | - | |
| Dec 17, 2020 | Perelman Ronald O | 10% Owner | Buy | 625,000 | $1.60 | $1,000,000.00 | +1.7% | - | - | |
| Dec 10, 2020 | Perelman Ronald O | 10% Owner | Buy | 625,000 | $1.60 | $1,000,000.00 | +1.8% | - | - | |
| Nov 24, 2020 | Perelman Ronald O | 10% Owner | Buy | 625,000 | $1.60 | $1,000,000.00 | +1.8% | - | - | |
| May 15, 2020 | Kozlov Hersh | Director | Buy | 10,000 | $3.00 | $30,000.00 | +200.0% | - | - | |
| May 12, 2020 | Perelman Ronald O | 10% Owner | Buy | 625,000 | $1.60 | $1,000,000.00 | +1.8% | - | - |